NCT01087268 Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer Status UNKNOWN Phase PHASE3
NCT01068249 Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01065662 AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies Status COMPLETED Phase PHASE1
NCT01049126 Retrospective Case Study Examining Patient Outcomes Compared to the ChemoFx Assay in Endometrial Cancer Patients Status COMPLETED Phase N/A
NCT01045187 Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer Status COMPLETED Phase NA
NCT01013324 Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Carcinoma Status COMPLETED Phase PHASE2
NCT00982631 A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer Status UNKNOWN Phase PHASE1
NCT00919919 Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen Status UNKNOWN Phase PHASE2
NCT00916708 Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients Status UNKNOWN Phase NA
NCT00910091 The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer Status COMPLETED Phase PHASE2
NCT00909896 Study of Post Operative Pain in Endometrial Cancer Robotic Versus Laparotomy Status COMPLETED Phase N/A
NCT00905658 Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer Status UNKNOWN Phase PHASE2
NCT00900562 Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy Status TERMINATED Phase PHASE2
NCT00883116 A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer Status TERMINATED Phase PHASE3
NCT00870337 Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer Status COMPLETED Phase PHASE2
NCT00842452 Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE1